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Forkhead box O (FOXO) transcription factors are regulators of cell-type specific apoptosis
and cell cycle arrest but also control longevity and reactive oxygen species (ROS).
ROS-control by FOXO is mediated by transcriptional activation of detoxifying enzymes
such as Superoxide dismutase 2 (SOD2), Catalase or Sestrins or by the repression
of mitochondrial respiratory chain proteins resulting in reduced mitochondrial activity.
FOXO3 also regulates the adaptation to hypoxia by reducing mitochondrial mass
and oxygen consumption during HIF-1α activation. In neuronal tumor cells, FOXO3
triggers ROS-accumulation as a consequence of transient mitochondrial outer membrane
permeabilization, which is essential for FOXO3-induced apoptosis in these cells. Cellular
ROS levels are affected by the FOXO-targets Bim, BclxL, and Survivin. All three
proteins localize to mitochondria and affect mitochondrial membrane potential, respiration
and cellular ROS levels. Bim-activation by FOXO3 causes mitochondrial depolarization
resulting in a transitory decrease of respiration and ROS production. Survivin, on the
other hand, actively changes mitochondrial architecture, respiration-efficacy and energy
metabolism. This ability distinguishes Survivin from other anti-apoptotic proteins such as
BclxL, which inhibits ROS by inactivating Bim but does not alter mitochondrial function.
Importantly, FOXO3 simultaneously also activates ROS-detoxification via induction of
SESN3. In this paper we discuss the hypothesis that the delicate balance between
ROS-accumulation by Bim-triggered mitochondrial damage, mitochondrial architecture
and ROS-detoxifying proteins determines cell fate. We provide evidence for a FOXO
self-reactivating loop and for novel functions of FOXO3 in controlling mitochondrial
respiration of neuronal cells, which further supports the current view that FOXO
transcription factors are information-integrating sentinels of cellular stress and critical
modulators of cell homeostasis.
Keywords: forkhead transcription factor, Bcl2-rheostat, BH3-only proteins, mitochondrial respiration,mitochondrial
fission
THE FAMILY OF FORKHEAD BOX O TRANSCRIPTION
FACTORS
The family of mammalian forkhead box O (FOXO) tran-
scription factors consists of the four members FKHR/FOXO1,
FKHRL1/FOXO3, AFX/FOXO4, and FOXO6 which regulate
apoptosis and cell cycle, immune response, energy state, stress
resistance, and longevity. Although all four mammalian FOXO
transcription factors share the same DNA binding motives (Obsil
and Obsilova, 2011) and seem to have overlapping functions,
knock out animals for single FOXO family members show dif-
ferent defects (Arden, 2008). FOXO1 knockout mice die in utero
due to defective vasculature (Hosaka et al., 2004), FOXO3 knock-
out mice suffer from organ inflammation resulting from defective
development of regulatory T-cells (Harada et al., 2010; Kerdiles
et al., 2010). In contrast FOXO4 and FOXO6 knockout mice
present with mild phenotypes (Zhu et al., 2011; Salih et al.,
2012). Conditional triple-knock-out in the adult mouse causes
a relatively mild neoplastic phenotype, i.e., these mice develop
hemangiomas and thymic lymphomas, which suggests that
FOXO1, FOXO3, and FOXO4 are involved in the maintenance
of the hematopoietic stem cell population and the regulation of
endothelial cell homeostasis (Paik et al., 2007; Tothova et al.,
2007). In cultured neuroblastoma cells the activation of FOXO3
triggers the intrinsic death pathway and induces programmed cell
death via induction of the pro-apoptotic BH3-only proteins Bim
and Noxa (Obexer et al., 2007). In addition FOXO3 represses the
apoptosis-inhibitor protein Survivin (Guha et al., 2009; Obexer
et al., 2009) and determines the sensitivity of neuroblastoma cells
to DNA-damaging chemotherapeutic agents. More recently it was
shown that beside its function as a tumor-suppressor FOXO3
might also promote cancer cell survival. FOXO3 induces detox-
ification and stress resistance thereby contributing to tumor stem
cell renewal (Naka et al., 2010) and protection of cancer cells from
eradication during chemotherapy (Hui et al., 2008) and hypoxia
(Bakker et al., 2007).
In this article we will discuss the current knowledge on the
involvement of FOXO transcription factors in the regulation
of cellular homeostasis with specific emphasis on mitochon-
drial integrity, morphology and activity. In addition we present
our hypothesis that FOXO3 controls a delicate balance between
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mitochondrial reactive oxygen species (ROS)-generation and
ROS-preventing or detoxifying processes, which is critical for cell
death decision in neuronal cells.
GROWTH FACTOR SIGNALING INACTIVATES FOXO
TRANSCRIPTION FACTORS
The activity and subcellular localization of FOXO transcription
factors (except FOXO6) is regulated by various upstream regula-
tors that modify FOXO proteins via phosphorylation, acetylation,
methylation and mono/poly-ubiquitination (Eijkelenboom and
Burgering, 2013). Phosphorylation at conserved serine/threonine
residues by protein kinase B (PKB) and by serum- and
glucocorticoid-induced kinase (SGK) induces the association
of FOXO transcription factors with 14-3-3 proteins and their
nuclear export and inactivation (Tzivion et al., 2011). This evo-
lutionary conserved FOXO-inactivating pathway directly links
FOXO activity to insulin and insulin-like growth factor signal-
ing, suggesting that under normal growth conditions, FOXOs
are inactivated and dispensable for the survival of cells. Similar
to PKB and SGK, IkB-kinase (IKK) and extracellular-signal reg-
ulated kinase (ERK) phosphorylate distinct serines (Ser644 of
FOXO3 by IKK and Ser294, Ser344, Ser425 of FOXO3 by ERK)
thereby causing FOXO-inactivation (Figure 1). Importantly,
phosphorylation by PKB, IKK, and ERK also constitutes a signal
for poly-ubiquitination and proteasomal degradation of FOXO
transcription factors thereby, in addition to functional inactiva-
tion, also reducing protein steady state levels (Matsuzaki et al.,
2003; Hu et al., 2004; Yang et al., 2008).
STRESS KINASE CASCADES THAT ACTIVATE FOXO IN
RESPONSE TO ROS AND DNA-DAMAGE
First evidence for the participation of FOXO transcription factors
in ROS regulation was found in C.elegans studying the FOXO3
homologue DAF-16. There, DAF-16 regulates a stress-resistant-
state, where metabolism is shut down and the worm enters
so called Dauer-formation to extend lifespan during nutrient
deprivation (Braeckman and Vanfleteren, 2007). FOXO3 is also
thought to participate in longevity regulation by detoxification of
ROS. Several groups found the mitochondrial enzyme superoxide
dismutase 2 (SOD2) (Kops et al., 2002), the peroxisome-located
Catalase (CAT) (Tan et al., 2008), the antioxidant enzyme perox-
iredoxin III (Chiribau et al., 2008) or the redox enzyme sestrin3
(SESN3) (Chen et al., 2010; Hagenbuchner et al., 2012a) induced
by FOXO in different tissues. Also the growth arrest and DNA
damage repair enzyme GADD45a is activated after stress signal-
ing by FOXO transcription factors and contributes to the survival
of damaged cells and stress resistance (Furukawa-Hibi et al.,
2002).
Cellular stress induced by accumulation of ROS or DNA-
damage overrides the growth factor-induced functional inacti-
vation of FOXO. The response to ROS involves Jun-N-terminal
kinase (JNK) and mammalian STE20-like protein kinase 1
(MST1) which phosphorylate FOXO transcription factors directly
(Essers et al., 2004; Lehtinen et al., 2006; Sunters et al., 2006)
or also target its binding partner 14-3-3 protein (Sunayama
et al., 2005). The direct phosphorylation by JNK or MST1
induces the release of FOXO3 from 14-3-3 proteins and causes
FIGURE 1 | Control of FOXO function downstream of growth-factor
and stress-induced kinase signaling cascades. Growth factor signaling
via protein kinase B (PKB), serum- and glucocorticoid-induced kinase (SGK),
IkB-kinase (IKK), and extracellular-signal regulated kinase (ERK) causes
inactivation of FOXO transcription factors and their export from the nucleus.
Jun-N-terminal kinase (JNK) and mammalian STE20-like protein kinase 1
(MST1) that are activated upon cellular stress, induce the nuclear
accumulation of FOXOs. A main trigger of JNK activation is accumulation of
cellular reactive oxygen species (ROS) which together with DNA-damage
also activate ataxia telangiectasia mutated (ATM) kinase and induce the
interaction between ATM and FOXO and its nuclear accumulation.
AMP-activated kinase (AMPK) functions as a cellular energy sensor that
increases the activity of nuclear FOXO factors. AMPK thereby acts in
concert with either low growth factor availability or high cellular stress and
further steers FOXO target recognition.
nuclear accumulation. However, as phosphorylation occurs at a
conserved serine in the forkhead domain (Ser209 of FOXO3)
it has not been completely clarified, how this phosphorylation
affects consensus sequence recognition by FOXO3. According to
crystal structures and band shift analyses (Brent et al., 2008),
DNA binding by FOXO1 is reduced or event abrogated suggesting
that during activation by JNK or MST1, FOXO might at least in
part interact with other transcription factors such as p53 (Chung
et al., 2012) or c-Myc (Ferber et al., 2012) and thereby regulate
target gene expression.
An important sensor of DNA-damage response is the ataxia
telangiectasia mutated (ATM), a member of the phosphoinositol-
3-kinase-like kinase family. ATM coordinates together with ATM-
related kinase (ATR) the cellular response to DNA-damage by
activating DNA-repair and signaling pathways. ATM senses DNA
double strand breaks and is also activated by ROS in mammalian
cells (reviewed in Ditch and Paull, 2012). ATM interacts with
FOXO3 and p53 during DNA-damage (Tsai et al., 2008; Chung
et al., 2012) and ROS-response (Yalcin et al., 2008) suggesting
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that these proteins are tightly interconnected during stress sig-
naling. We recently provided evidence that the FOXO3-ATM
complex also overcomes epigenetic silencing of the caspase-8 gene
in human neuroblastoma cells by activating the ATMdownstream
target CREB which in turn triggers methylation-independent
activation of the caspase-8 promoter (Geiger et al., 2012).
AMP-activated kinase (AMPK) is a sensor of cellular energy
homeostasis and is activated by high AMP to ATP ratios. AMPK
phosphorylates FOXO3 on at least six different serine/threonine
residues (Thr179, Ser399, Ser413, Ser439, Ser555, Ser588, and
Ser626), which does not change subcellular localization of FOXO3
but increases its transcriptional activity and may modulate dif-
ferential promoter recognition (Greer et al., 2007). AMPK only
phosphorylates nuclear FOXO3 thereby acting in concert with
growth factor withdrawal or cellular stress signals. The exact
mechanism of FOXO3 transcriptional activation by AMPK has
not been completely elucidated but phosphorylation by AMPK
increases the interaction with CREB-binding protein (CBP)
(Wang et al., 2012) and p300 which both affect FOXO3 tran-
scriptional activity and promoter recognition by acetylation.
Phosphorylation of FOXO by AMPK has been linked to FOXO-
induced autophagy (Chiacchiera and Simone, 2009), neuronal
cell death (Davila et al., 2012), and muscle atrophy (Sanchez
et al., 2012). Importantly, fission of mitochondria triggers AMPK
activation and FOXO3-induced autophagy, which removes mito-
chondria and contributes to muscle atrophy (Romanello et al.,
2010). This suggests an energy-sensing network between AMPK,
FOXO3 and mitochondrial architecture.
STEERING FOXO FUNCTION BY ACETYLATION,
METHYLATION AND INTERACTIONWITH OTHER
TRANSCRIPTION FACTORS
Besides kinase cascades FOXO transcription factors are subject
to additional post-translational modifications such as acetyla-
tion/deacetylation processes, most prominent via acetylation of
lysines in the forkhead domain by CBP/p300 (Wang et al., 2012)
or deacetylation by the protein deacetylase sirtuin-1 (SIRT1)
(Brunet et al., 2004; Kobayashi et al., 2005). Whereas acetylation
enhances the expression of pro-apoptotic FOXO-targets, SIRT1
modulates the transcriptional function of FOXO3 in a way which
inhibits FOXO3-induced expression of pro-apoptotic genes and
increases the expression of genes involved in cell-cycle regulation,
DNA-repair and stress resistance. FOXO-deacetylation by SIRT1
may therefore also contribute to longevity and survival of tumor
cells, questioning the general view of FOXOs as tumor suppres-
sor proteins (reviewed in (Calnan and Brunet, 2008). Another
posttranslational modification is methylation by protein argi-
nine methyltransferases (PRMT) 1 and 6 that add methyl groups
to arginine on substrate proteins. In the case of FOXO tran-
scription factors, PRMT1 targets arginine Arg248 and Arg250
(of FOXO1) within the PKB consensus motive, which prevents
PKB-mediated phosphorylation of Ser256 (FOXO1). As a con-
sequence nuclear export in presence of active PKB is inhibited
and the transcriptional activity of FOXO transcription factors
is increased (Yamagata et al., 2008). In contrast SET-domain
containing protein 7 (SETD7/SET9), a lysine-methyltransferase
was shown to methylate Lys270 in FOXO3, which inhibits
DNA-binding, induction of FOXO3 target genes such as Bim and
neuronal apoptosis (Xie et al., 2012). Therefore protein methyla-
tion significantly steers the activity of FOXO transcription factors
and also affects their posttranslational modification by protein
kinases.
Furthermore, FOXO proteins have been shown to cooperate
with cofactors such as Smad3/4, p53, as well as with nuclear
androgen-, glucocorticoid- and retinoic acid receptors (reviewed
in, Calnan and Brunet, 2008; van der Vos and Coffer, 2008).
Recently it was also shown that FOXO3 interacts with β-catenin
and that this interaction converts the transcriptional activity
of FOXO3 to promote metastasis instead of apoptosis in colon
cancer (Tenbaum et al., 2012).
A recent report suggests that FOXOs may also directly mea-
sure the redox status in a cell via reversible oxidation/reduction
of cysteine. Oxidation of cysteines in FOXO proteins causes the
covalent binding of p300 and CBP via disulfide bonds. These
modifications directly affect the transcriptional activity of FOXO
transcription factors and thereby allow them to act as sensors of
cellular redox status (Dansen et al., 2009). Together with phos-
phorylation by oxidative stress induced kinases such as JNK or
MST1, this mechanism may directly affect target gene regulation
by FOXO transcription factors andmodulate the cellular response
to ROS.
FOXO3 AS A TRIGGER FOR MITOCHONDRIAL ROS
Although FOXO3 has been shown to induce a number of genes
that protect against ROS suggesting that they play a critical
role in keeping cellular ROS low, we recently demonstrated
that in primary neurons and neuroblastoma cells FOXO3 may
also increase mitochondrial ROS levels (Hagenbuchner et al.,
2012a). The accumulation of ROS was essential for FOXO3-
induced cell death in these cell types, since co-treatment with
the ROS inhibitor N-Acetyl-L-cystein (NAC) rescued neurob-
lastoma cells from FOXO3-induced apoptosis. This uncovers an
interesting possible feedback regulation between ROS and FOXO3
at mitochondria: on one hand FOXO3 is activated in response
to elevated cellular ROS levels and on the other hand FOXO3
itself triggers ROS accumulation by interrupting mitochondrial
outer membrane integrity. To investigate such a possible self-
amplifying regulation we infected SH-EP/FOXO3 cells that carry
a conditional 4OHT-activated FOXO3ERtm fusion protein with
a retrovirus coding for a wild-type ECFP-FOXO3 fusion pro-
tein. This ECFP-FOXO3 fusion protein can be used to monitor
FOXO3 nuclear accumulation by live cell fluorescencemicroscopy
in response to various stimuli (Obexer et al., 2009; Geiger et al.,
2012; Hagenbuchner et al., 2012a,b). In SH-EP neuroblastoma
cells the PI3K-PKB signaling pathway is highly active, which
causes cytoplasmic retention of FOXO3 (Obexer et al., 2007,
2009). In these cells, we studied whether activation of the con-
ditional, PKB-independent FOXO3 allele and FOXO3-induced
increase of mitochondrial ROS constitutes a signal to activate
cellular FOXO3 protein despite active PKB. A first ROS accu-
mulation was observed already 4 h after FOXO3-activation and
at this time point ECFP-FOXO3wt is already equally distributed
between nucleus and cytoplasm of the majority of the cells.
Interestingly at 6 h, when the first ROS wave already declines,
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wild-type ECFP-FOXO3 accumulates in the nucleus of the neu-
roblastoma cells (Figure 2). This supports the hypothesis that
some active FOXO3 molecules within a cell may trigger also
the nuclear accumulation and thereby hyper-activation of other
FOXO3 molecules. The primary, partial activation of FOXO
increases the levels of pro-apoptotic Bim, which in turn causes
damage to mitochondria, partial release of Cytochrome-c and
increased ROS production (Hagenbuchner et al., 2012a). The sec-
ondary FOXO3 activation might at least in part be regulated by
the first ROS accumulation and explain why some FOXO3 tar-
gets are immediately activated, such as Bim, whereas others are
induced (such as p27Kip1, data not shown) or repressed (such as
BclxL), (Hagenbuchner et al., 2012a) in delay. Although the rele-
vance of ROS in this FOXO3-induced FOXO3 activation has to be
proven, these observations support the hypothesis that oxidative
stress activates FOXO3, which enhances further mitochondrial
ROS and that this feedback-loop causes an avalanche-like, sec-
ondary activation of additional FOXO3 molecules leading to
the second wave of ROS accumulation and apoptotic cell death
(Figure 2).
THE CONNECTION BETWEEN FOXO, PRO-APOPTOTIC Bcl2
PROTEINS, RESPIRATION AND ROS
When analyzing the events that lead to the first accumulation
of ROS at the mitochondria, we identified the pro-apoptotic
FOXO3-target Bim as a trigger of transitory mitochondrial outer
membrane permeabilization. Bim is rapidly induced (within
2–8 h) by FOXO3 (Obexer et al., 2007), leading to translocation
FIGURE 2 | FOXO3 activation causes biphasic ROS accumulation at
mitochondria leading to feed forward activation and apoptosis. SH-EP
neuroblastoma cells expressing a conditional FOXO3-ERtm protein were
treated with 4-OH-tamoxifene (4OHT), which leads to functional activation of
this transgene. FOXO3 induces a first ROS accumulation at 4 h with complete
SESN3-dependent decay of ROS between 8 and 14h and strong secondary
accumulation of ROS afterwards that finally leads to apoptotic cell death.
Accumulation of ROS was detected using MitoTracker Red CMH2XROS
(Invitrogen) by live-cell imaging in an Axiovert200M microscope (Zeiss) (A).
Subsequent to the first ROS peak triggered by FOXO3(A3)ERtm nuclear
accumulation of ECFP-FOXO3wt is observed suggesting amplifying feed
forward activation of additional FOXO3 molecules after primary FOXO3
activation (B). Apoptosis was determined by Annexin-V staining in a FC500
flow cytometer (Beckman-Coulter) (C). The chronology of cellular events in
response to FOXO3 activation: after 4 h ECFP-tagged FOXO3 starts to
accumulate in the nucleus (blue line, data based on quantification of nuclear
FOXO3 by live cell imaging analysis), ROS accumulates first after 4 h,
followed by decay to background ROS levels and a second much more
intensive ROS accumulation (red line) that also marks the onset of cell death
(black line, based on time course experiments using flow cytometric analysis
of annexin-V staining). The data was compiled from analyses shown in (A–C),
additional unpublished data or data from (Hagenbuchner et al., 2012a) (D).
Model of cell death/stress resistance regulation by FOXO3 involving the
biphasic accumulation of mitochondrial ROS downstream of Bim, which may
constitute a feed forward signal to overcome the ROS-protective capacity of
SESN3 (E).
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of Bax and to a first minor release of Cytrochrome-c, which
correlates with the first ROS accumulation (Hagenbuchner
et al., 2012a). Knock-down of Bim rescues neuroblastoma
cells from ROS-accumulation and FOXO3-induced apoptosis,
whereas tetracycline-regulated Bim-expression alone is sufficient
to induce ROS. These observations imply that FOXO3 interrupts
mitochondrial function by transient outer membrane permeabi-
lization via Bim, which results in Bax/Bak activation and in leak-
ing out of the electron-acceptor Cytochrome-c (Hagenbuchner
et al., 2012a). As a result of inefficient electron transfer ROS accu-
mulate at mitochondria. The amount of released Cytochrome-c
seems not sufficient in these neuronal cells to induce immedi-
ate apoptosome-mediated caspase-9 activation and cell death,
as first signs of apoptosis are evident much later after 18–24 h.
Whereas the knock-down of Bim prevents FOXO3-induced ROS
accumulation and cell death induction shRNA-mediated elim-
ination of Noxa/PMAIP1, another BH3-only protein that is
directly regulated by FOXO3 in neuronal cells, does not influ-
ence FOXO3-induced ROS accumulation. This suggests that a
weak BH3-only protein such as Noxa, which cannot induce
apoptosis by itself but acts as apoptosis-sensitizer is also not
potent enough to cause ROS accumulation at mitochondria.
The hypothesis that mitochondrial apoptosis is directly con-
nected to transitory permeabilization of the outer mitochon-
drial membrane leading to mitochondrial ROS accumulation is
further supported by the Bim-neutralizing pro-survival protein
BclxL: if overexpressed BclxL not only prevents FOXO3-induced
cell death but also the biphasic ROS accumulation thereby
directly linking FOXO3-induced ROS to the balance of pro-
and antiapoptotic Bcl2 proteins at mitochondria (Figures 2, 4).
Simultaneously with Bim induction and ROS accumulation,
mitochondrial respiration drops to about 70% of untreated con-
trols, but recovers again to 99% after decay of the first ROS
wave (Hagenbuchner et al., 2012a). Consistent with the hypoth-
esis that FOXO3-induced mitochondrial ROS results from the
detrimental effects of Bim on mitochondrial function, Bim over-
expression causes a significant drop of respiration that coincides
with high levels of ROS. On the other hand the overexpres-
sion of BclxL, which is repressed by FOXO3, also efficiently
preserves respiration during FOXO3-activation (Hagenbuchner
et al., 2012a). This suggests that FOXO3-activation by e.g., oxida-
tive stress causes an imbalance of FOXO3-regulated Bcl2 proteins
in neuronal cells leading to partial membrane permeabilization,
transitory decrease in respiration and accumulation of ROS at
mitochondria.
In contrast to these “acute FOXO3 effects” on mitochon-
dria in neuronal cells additional mechanisms have been dis-
covered how FOXO3 regulates mitochondrial mass, respiration
and ROS production. Two groups recently demonstrated that
FOXO3 is activated downstream of hypoxia-inducible factor-
1α (HIF-1α) during hypoxia and is involved in the repres-
sion of nuclear-encoded mitochondrial genes during hypoxia.
In this case, FOXO3 controls the adaptation to low oxygen and
slowly shuts down mitochondrial activity by antagonizing c-
Myc function. Hypoxia usually increases ROS production from
mitochondria, which feeds back into stabilization of HIF-1α.
Under hypoxic conditions, FOXO3 prevents hypoxia-induced
ROS and HIF-1α stabilization by ROS, which contributes to
tumor growth in xenograft models (Jensen et al., 2011; Ferber
et al., 2012).
A third mechanism by which FOXO3 modulates mitochon-
drial activity is by directly regulating mitochondria-encoded
genes. In response to glucose restriction in fibroblasts and skeletal
muscle cells FOXO3 is phosphorylated by AMPK and subse-
quently imported into mitochondria where it forms a protein
complex containing FOXO3, SIRT3, and mitochondrial RNA
polymerase (mtRNAPol). This complex activates the expression
of mitochondria-encoded genes, increases mitochondrial respi-
ration and contributes to muscle adaptation during nutrient
restriction (Peserico et al., 2013). How this complex affects mito-
chondrial structure has not been investigated yet.
FOXO3-INDUCED MITOCHONDRIAL ROS—A BALANCE
BETWEEN LIFE AND DEATH?
So does FOXO3-induced early ROS accumulation already
define the non-reversible activation of programmed cell death?
Interestingly, after the first peak around 4 h after FOXO3 acti-
vation mitochondrial ROS almost completely goes back to base-
line (Figure 2A and red line in schematic presentation), which
suggests that in parallel to mitochondrial damage also rescue
pathways are activated. In a large number of different cell types
FOXO-transcription factors play a critical role in the detoxifica-
tion of ROS and several FOXO3-targets were described for this
cell-protective effect, among them SOD2, Catalase (Kops et al.,
2002; Hasegawa et al., 2008; Tan et al., 2008) peroxiredoxin III
(Chiribau et al., 2008) or the redox enzyme sestrin3 (SESN3)
(Chen et al., 2010). SOD2 and Catalase are critically involved in
the detoxification of superoxide-radicals and peroxide in various
cell types and their activity might explain the decay of ROS and
recovery of mitochondrial respiration after the first ROS peak
during FOXO3 activation. However, SOD2 and Catalase were
not regulated in neuroblastoma cells and therefore do not seem
to contribute to the fluctuations of ROS levels during FOXO3-
induced apoptosis (Hagenbuchner et al., 2012a). Neuronal cells
rely on the thiol-reducing system based on thioredoxin and glu-
tathione, which act as reducers of cellular peroxides (Budanov
et al., 2004). In Microarray analyses, however, we identified the
antioxidant enzyme SESN3 as a FOXO3 target in neuronal and
neuroblastoma cells. SESN3 has two different functions: it acts
as an antioxidant factor and is critical for the regeneration of
peroxiredoxins. On the other hand SESN3 is also an inhibitor
of target of rapamycin complex 1 (TORC1), which may affect
FOXO3 activation via the PKB pathway (Budanov and Karin,
2008; Chen et al., 2010). When SESN3 induction is abrogated by
short-hairpin technology this also prevents the transitory decline
in ROS during FOXO3 activation and accelerates FOXO3-induced
apoptosis in neuronal cells. This suggests that FOXO3 activate
both, ROS production via Bim-induced mitochondrial damage
and in parallel a ROS detoxifying pathway via SESN3. SESN3
induction and ROS detoxification therefore represent a rescue
pathway for neuronal cells after FOXO3 activation. The balance
between ROS-inducing and ROS-detoxifying molecular players
determines whether the cell undergoes FOXO3-induced apoptosis
or not.
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The second ROS accumulation observed after about 16 h
(Figure 2) is associated with phosphorylation of p66/SHC, a
splice variant of the growth factor SHC, which localizes to
mitochondria (Hagenbuchner et al., 2012b). Phosphorylation of
p66/SHC correlates with increased H2O2 production (Giorgio
et al., 2005), suggesting that prolonged FOXO3 activation over-
comes the protective effect of SESN3 and continuous oxidative
stress leads to phosphorylation of p66. Increased ROS finally
causes oxidation of the Cytochrome-c-binding protein cardi-
olipin, which results in elevated levels of free Cytochrome-c
in the inter-membrane space and finally to effective release
of Cytochrome-c from mitochondria and apoptosis induction
via apoptosome formation and caspase activation (reviewed in,
Huttemann et al., 2011).
MITOCHONDRIAL REORGANIZATION AND EFFECTS OF
FOXO3
Mitochondrial activity and connectivity regulates oxidative phos-
phorylation and thereby intracellular ATP production. Electrons
from energy rich NADH and FADH2 are transferred through
the chain of four large enzyme complexes, leading to a proton
flux via the inner mitochondrial membrane. As a side product,
mitochondrial respiration leads to production of ROS, mainly
through complex I, III and the reduced ubiquinol pool. ROS
from complex I are mainly released on the matrix side of mito-
chondria, whereas complex III releases ROS into the matrix and
the inter-membrane space. Within the inter-membrane space
free Cytochrome-c acts as natural ROS detoxifier by removing
unpaired electrons from superoxide leading to O2 formation and
by conversion of hydrogen peroxide. During apoptosis induction,
ATP production is reduced and mitochondria undergo reorgani-
zation to release Cytochrome-c into the cytosol which leads to
a sharp increase of ROS from complex I (reviewed in, Sena and
Chandel, 2012).
The mitochondrial shape and size are controlled by mem-
bers of the fusion/fission family which, together with the Bcl2
family, control mitochondrial fragmentation and Cytochrome-
c release (Karbowski et al., 2006; Sheridan et al., 2008). The
main mammalian fission protein is the GTPase dynamin-related
protein 1 (DNM1L/Drp1), whose activity is mainly regulated
by phosphorylation at Ser616 and Ser637. Ser616 phosphory-
lation by Cdk1/cyclinB affects GTPase effector domain (GED)
function and leads to translocation of Drp1 to the mitochon-
dria during mitosis. De-phosphorylation on Ser637 is thought
to be mediated by calcineurin which facilitates the translo-
cation of Drp1 to distinct foci at the outer membrane of
mitochondria, where oligomerization of Drp1 induces the frag-
mentation of mitochondrial networks into single mitochondria
(reviewed in, Elgass et al., 2013). Other regulators of mitochon-
drial fusion, mitofusin 1 and 2 (MFN1 and MFN2) and optic
atrophy1 (OPA1) also regulate mitochondrial fusion dynam-
ics. MFN1 and MFN2 are located at the mitochondrial outer
membrane and are responsible for connecting separate mito-
chondria. OPA1 is localized inside the intermembrane space and
cooperates with MFN1 and MFN2 to fuse the inner and outer
membranes of different mitochondria (reviewed in, Elgass et al.,
2013).
Drp1, MFN1, and MFN2 were shown to cooperate with
distinct members of the Bcl2 family in the reorganization of
mitochondria during apoptosis induction. Active Drp1 facilitates
Bax oligomerization during outer membrane permeabilization
(Karbowski et al., 2006). BclxL and Bcl2 can bind MFN2, but
notMFN1 and BclxL also interacts with Drp1, which interestingly
increases its GTPase activity and leads to apoptosis-independent
fragmentation of mitochondria in specific cell types (Delivani
et al., 2006; Sheridan et al., 2008). Therefore, BclxL can promote
either fusion or fission, even in the same cell type.
So how does FOXO3 affect mitochondrial architecture in neu-
ronal cells? We observed de-phosphorylation of Drp1 at Ser637
and its translocation to the mitochondria 8 h after FOXO3 acti-
vation, suggesting that Bim-induced ROS may lead to cellular
stress-induced de-phosphorylation of Drp1 (Hagenbuchner et al.,
2012b). At the same time, Bax is recruited to the mitochondria
and small amounts of Cytochrome-c are released to the cyto-
plasm. After 24 h FOXO3 induces MFN1 and MFN2 expression,
which correlates with the onset of apoptosis and reorganization
of mitochondria. Ectopic expression of BclxL not only blocked
Cytochrome-c release and apoptosis by sequestering Bim but also
prevented the induction of the fusion/fission machinery pro-
teins by FOXO3 (Hagenbuchner et al., 2012b). This implies that
induction of Bim and repression of BclxL by FOXO3 signifi-
cantly affect the mitochondrial fusion/fission machinery via Drp1
recruitment, which, in addition to ROS accumulation and BH3-
only-induced Bax-oligomerization may contribute to FOXO3-
induced Cytochrome-c release and apoptosis (Hagenbuchner
et al., 2012b). Beyond Bcl2-family members FOXO3 affects mito-
chondrial activity and shape also via regulating the FOXO3 target
Survivin.
SURVIVIN UNCOUPLES MITOCHONDRIAL FISSION FROM
CYTOCHROME-c RELEASE AND APOPTOSIS INDUCTION
Survivin belongs to the family of Inhibitors of Apoptosis Proteins
(IAPs) and was reported to inhibit apoptosis only when located
to the mitochondria (Dohi et al., 2007; Obexer et al., 2009).
Survivin contains the characteristic zinc-binding BIR domain
but lacks the typical RING domain of other IAP family mem-
bers. Apoptosis inhibition was ascribed to the ability of Survivin
to directly bind and stabilize XIAP, which directly interferes
with caspase activation (Dohi et al., 2004). These mechanisms
suggest that Survivin prevents apoptosis downstream of mito-
chondria. However, in neuroblastoma cells we observed a dif-
ferent mode of action of Survivin: Survivin mRNA expression
is rapidly repressed by FOXO3 and this leads to rapid loss of
cytoplasmic Survivin, whereas mitochondrial Survivin shows sig-
nificantly higher stability. Ectopically expressed Survivin reduces
the number of CMXRos-negative cells during FOXO3-activation,
suggesting a role for Survivin at the level of mitochondria (Obexer
et al., 2009). In concordance we observed that Survivin pre-
vents Bax accumulation at the mitochondria and the release
of Cytochrome-c into the cytoplasm after FOXO3-activation.
Interestingly, Survivin interferes with FOXO3-induced ROS accu-
mulation. Similar to knock-down of Bim or ectopic expression of
BclxL, Survivin inhibits FOXO3-induced ROS, Bax activation and
Cytochrome-c release (Hagenbuchner et al., 2012b). In contrast
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to BclxL, which prevents Drp1 accumulation at mitochondria,
Survivin-overexpressing cells showed increased Drp1 levels but
reduced Drp1 phosphorylation (unpublished data) and there-
fore significantly higher amounts of mitochondria-associated
Drp1 than control cells (Hagenbuchner et al., 2012b). These
increased Drp1 levels resulted in fragmented mitochondria in
Survivin-expressing cells (Figure 3). The mitochondrial fission
phenotype is reversibly either by the use of the Drp1-inhibitor
FIGURE 3 | The FOXO3-target Survivin reduces mitochondrial respiration
and induces mitochondrial fission in neuronal tumor cells via Drp1
recruitment to mitochondria. Ectopic expression of the anti-apoptotic
protein Survivin in neuroblastoma cells reduces basal and FCCP-activated
mitochondrial respiration to about one third of control cells. Oxygen
consumption of the cells and mitochondrial function were analyzed by
high-resolution respirometry (Kuznetsov et al., 2008), using a two-channel
Oroboros Oxygraph respirometer. This reduced respiratory activity results
from almost absence of respiratory complex I activity (data not shown;
∗∗∗P < 0.001, student’s t-test) (A). Survivin recruits DNM1L/Drp1 to
mitochondria and induces mitochondrial fission. Microscopic images were
acquired on an Axiovert200M microscope equipped with an Apotome_2
module (B). Mitochondrial fission is associated with apoptosis-protection and
significantly reduced capability to accumulate ROS in response to FOXO3
activation or treatment with chemotherapeutic agents (see text)
(Hagenbuchner et al., 2012b).
FIGURE 4 | A conceptional view on how FOXO3 regulates mitochondrial
ROS and apoptotic cell death in neuronal cells and neuroblastoma
tumor cells. Transitory induction of pro-apoptotic Bim by FOXO3 constitutes
a first mitochondria-damaging signal that triggers the primary ROS peak at
4 h. In parallel the ROS-detoxifying SESN3 accumulates and critically
regulates decay of the ROS after 4–6h. Bim-neutralizing BclxL and Survivin
are both repressed by FOXO3, thereby lowering the ability of the cell to cope
with apoptosis-inducing signals. This concerted regulation of pro- and
anti-apoptotic ROS-affecting proteins overcomes the protective effect of
SESN3 after about 16h leading to a sharp and continuous increase in ROS,
which finally leads to apoptotic cell death. The schematic presentation is
based on several time-course immunoblot experiments and data from
fluorescence-based mitochondrial ROS measurements not included in this
paper.
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Mdivi-1 or by knock-down of Drp1 with short-hairpin technol-
ogy, which both lead to mitochondrial fusion. Also the reduction
of Survivin levels reverses the mitochondrial phenotype, suggest-
ing that Survivin actively contributes to mitochondrial fission
via Drp1 recruitment. In contrast to the current dogma that
Drp1 translocation to mitochondria and mitochondrial fission is
associated with apoptosis induction the Survivin-induced fission
even protects cells against FOXO3-induced apoptosis and con-
fers resistance to chemotherapeutic agents (Hagenbuchner et al.,
2012b). This protective effect is associated with efficient inhi-
bition of FOXO3-induced ROS, which may be ascribed at least
in part to significant reduction of mitochondrial respiration by
Survivin. In neuronal tumor cells moderate overexpression of
Survivin lowers endogenous respiration to about one third of
control cells via inactivation of respiratory complex I (Figure 3).
Survivin-induced changes of mitochondrial shape andmitochon-
drial respiration reprograms cellular energy metabolism so that
the cells become dependent on glycolysis and sensitive to glycoly-
sis inhibitors (Hagenbuchner et al., 2012b). Thereby, by affecting
cellular Survivin expression FOXO3 affects mitochondrial shape,
respiratory activity and energy metabolism.
FOXO3 was originally described as a tumor-suppressor pro-
tein that activates cell death inducers such as TRAIL, Fas
ligand, Bim or Noxa or controls detoxification of ROS. In
the meantime this view has been challenged as it was shown
that FOXO3 may also control mitochondrial respiration dur-
ing adaptation to hypoxia or is even imported into mito-
chondria to regulate expression of mitochondrial genes. The
fact that FOXOs are inactive under optimal growth condi-
tions suggests that these transcription factors function as home-
ostasis regulators during stress rather than as typical tumor
suppressors. According to our recent studies FOXO3 induces
mitochondrial ROS as an essential second messenger during
Bcl2-protein controlled apoptotic cell death but also detoxi-
fying proteins that counteract ROS accumulation (Figure 4).
Importantly, FOXO3 also represses the proto-oncogene Survivin,
which we discovered to regulate the mitochondrial fusion/fission
machinery and mitochondrial respiration by interfering with
complex I activity. By this, the FOXO3-target Survivin repro-
grams energy metabolism and activates glycolysis to produce
energy for survival. So FOXO3 is a transcription factor that
directly or indirectly affects mitochondrial respiration, ROS
accumulation and even mitochondrial shape, which on one
hand affects apoptosis sensitivity of tumor cells, but also
may have significant impact on life-span in multicellular
organisms.
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